Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy

Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O. , ...More

JOURNAL OF CRITICAL CARE, vol.30, no.6, pp.1179-1183, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1016/j.jcrc.2015.07.014
  • Title of Journal : JOURNAL OF CRITICAL CARE
  • Page Numbers: pp.1179-1183


Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.